Site icon OncologyTube

CheckMate -214 Study Reveals Which Patients with Advanced Kidney Cancer Benefit from Nivolumab + Ipilimumab Combination

Saby George, MD, FACP, Roswell Park Cancer Institute, shares Checkmate-214 Not for All Kidney Cancer Patients | Study for Advanced Metastatic Kidney Cancer at Annual Meeting 2018

Exit mobile version